海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Stepping Up Study: A Cluster Randomised Controlled Trial of team-based transition to insulin in primary care compared to usual care to improve HbA1c for patients with poorly controlled type 2 diabetes
- Type 2 diabetes (T2D)
- Australia
- 2012-09-25
Not Recruiting
- A Study to test the Safety and Effectiveness of the Sitagliptin in Patients with Type 2 Diabetes Mellitus who are unable to Control their Blood Sugar Levels on Insulin with or without Metformin.
- Type 2 diabetes mellitus without complications
- Australia, Belgium, Brazil, Canada, Denmark, France, Germany, Guatemala, Hungary, India, Ireland, Israel, Italy, Lithuania, Mexico, New Zealand, Norway, Peru, Poland, Portugal, Russian Federation, South Africa, Spain, Turkey, United Kingdom, United States of America
- 2012-08-03
Authorised
- Safety and Efficacy Study of Pegylated Interferon Lambda with and without Daclatasvir, compared to Pegylated Interferon Alfa, plus Ribavirin in Subjects with Hepatitis C Genotype 2 and 3
- Chronic Hepatitis C MedDRA version: 16.0 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Finland, France, Greece, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Puerto Rico, Russian Federation, Singapore, Taiwan, United Kingdom, United States
- 2012-05-28
Recruiting
- Randomized phase III trial of 1 course BEP (Bleomycin, Etoposid, Cisplatin) versus 2 courses BEP adjuvant chemotherapy in patients with high-risk non-seminomatous germ cell tumors - AH 10/04
- testicular tumor;C62 - Malignant neoplasm of testis
- Australia, Belgium, France, Germany, Netherlands, Norway, Poland, Slovakia, Spain, Turkey
- 2012-04-27
Not recruiting
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
- Hemophilia A;Hemophilia A;Hemophilia A;Hemophilia A
- Australia, Hong Kong, Ireland, Netherlands, Poland, South Africa, United Kingdom, United States
- 2011-10-20
Not Recruiting
- Comparison of a new formulation of insulin glargine with Lantus in patients with type 2 diabetes mellitus on basal plus mealtime insulin
- Type 2 Diabetes Mellitus MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Canada, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Mexico, Netherlands, South Africa, Sweden, United States
- 2011-08-22
Not Recruiting
- Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years
- Paediatric dilated cardiomyopathy and symptomatic chronic heart failure MedDRA version: 16.0 Level: LLT Classification code 10008908 Term: Chronic heart failure System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Australia, Brazil, Denmark, Finland, Germany, Hungary, Italy, Mexico, Portugal, Russian Federation, Spain, Sweden, United Kingdom
- 2011-08-19
- A RANDOMIZED, OPEN-LABEL, MULTI-CENTRE STUDY TO EVALUATE PATIENT PREFERENCE WITH SUBCUTANEOUS ADMINISTRATION OF RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH CD20+ DIFFUSE LARGE B-CELL LYMPHOMA OR CD20+ FOLLICULAR NON-HODGKIN’S LYMPHOMA GRADES 1, 2 OR 3A
- -C833 Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma;Diffuse large B-cell lymphoma
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Croatia, Dominican Republic, Egypt, El Salvador, France, Germany, Guatemala, Hungary, Indonesia, Italy, Korea North, Korea South, Malasya, New Zealand, Norway, Panama, Philippines, Portugal, Romania, Sweden, Switzerland, Taiwan, Thailand, Turkey
- 2013-10-25
Not recruiting
- Risk Factors and Response to Therapy in Heart and Lung Transplant Patients with Posttransplant Lymphoproliferative Disease
- Posttransplant Lymphoproliferative Disease
- Australia
- 2013-09-30
Not recruiting
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Canada, France, Italy, Mexico, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Thailand, United Kingdom, United States
- 2013-07-25
Recruiting
- Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents
- HIV Infections
- Puerto Rico, South Africa, Thailand, United States
- 2017-11-01
Not Recruiting
- Doxycycline to improve lymphedema due to podoconiosis
- Podoconiosis (Podo) Injury, Occupational Diseases, Poisoning
- Cameroon
- 2017-07-25
Authorised
- A study in people with type 2 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin
- Type II Diabetes Mellitus MedDRA version: 19.1 Level: LLT Classification code 10020639 Term: Hyperglycemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Argentina, Australia, Czech Republic, Germany, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Slovakia, Spain, Taiwan, United States
- 2017-04-04
Not Recruiting
- A Phase 3 study to Evaluate the Efficacy and Safety of Fitusiran in Patients with Hemophilia A or B, with Inhibitory Antibodies to Factor VIII or IX
- â?¢Hemophilia A â?¢Hemophilia B
- Australia, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, India, Israel, Italy, Japan, Malaysia, Netherlands, Portugal, Republic of Korea, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States of America
- 2018-06-29
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-06-06
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, United Kingdom, United States
- 2018-05-29
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-05-25
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-05-16
Authorised
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-04-20
Authorised
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-03-30